Literature DB >> 16403675

CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression.

Uma Malhotra1, Claire Huntsberry, Sarah Holte, Jean Lee, Lawrence Corey, M Juliana McElrath.   

Abstract

CD4+ T cell depletion and dysfunction are the hallmark of HIV-1 disease. Our primary objectives were to define the diversity of the CD4+ T cell receptor Vbeta (TCRBV) repertoire in subjects with HIV-1 infection by CDR3 (complementarity-determining region) length spectratyping and to determine the correlates of CD4+ repertoire perturbation and its restoration with virus suppression. During primary HIV-1 infection, the proportion of perturbed CD4+ TCRBV subfamilies was significantly greater compared to HIV-1 seronegative subjects (median 48% vs. 10%, P = 0.0159). During chronic infection, the extent of repertoire perturbation was significantly associated with higher levels of plasma viremia (Spearman Correlation coefficient, R = 0.65, P = 0.049) and disease progression. Restoration of the repertoire with antiretroviral therapy was variable despite adequate virologic suppression. We speculate that the use of immunomodulators as an adjunct to antiretroviral drugs may enhance immune reconstitution in persons with suboptimal increases in CD4+ T cell counts despite adequate virus suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16403675     DOI: 10.1016/j.clim.2005.11.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

1.  HIV viral diversity and escape from cellular immunity.

Authors:  Nicole Frahm; Christian Brander
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

2.  Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.

Authors:  Sarfraz A Memon; Claude Sportès; Francis A Flomerfelt; Ronald E Gress; Frances T Hakim
Journal:  J Immunol Methods       Date:  2011-10-01       Impact factor: 2.303

3.  Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie.

Authors:  Kellie N Smith; Robbie B Mailliard; Charles R Rinaldo
Journal:  For Immunopathol Dis Therap       Date:  2015

4.  Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.

Authors:  Mark A Jacobson; Dirk P Ditmer; Elizabeth Sinclair; Jeffrey N Martin; Steven G Deeks; Peter Hunt; Edward S Mocarski; Caroline Shiboski
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

Review 5.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.